Massachusetts Financial Services CO Bio Xcel Therapeutics, Inc. Transaction History

Massachusetts Financial Services CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$6.39 - $28.58 $1.66 Million - $7.41 Million	259,439 Added 71.26%	623,525 $4.15 Million
Q1 2023 May 10, 2023	SELL	$17.7 - $33.24 $1.62 Million - $3.03 Million	-91,280 Reduced 20.05%	364,086 $6.79 Million
Q4 2022 Feb 13, 2023	BUY	$10.25 - $22.43 $15,262 - $33,398	1,489 Added 0.33%	455,366 $9.78 Million
Q3 2022 Nov 09, 2022	BUY	$11.19 - $17.89 $345,278 - $552,013	30,856 Added 7.29%	453,877 $5.37 Million
Q2 2022 Aug 09, 2022	SELL	$9.03 - $21.55 $28,498 - $68,011	-3,156 Reduced 0.74%	423,021 $5.58 Million
Q1 2022 May 11, 2022	BUY	$15.0 - $22.83 $175,395 - $266,951	11,693 Added 2.82%	426,177 $8.91 Million
Q4 2021 Feb 10, 2022	SELL	$20.12 - $35.09 $60,883 - $106,182	-3,026 Reduced 0.72%	414,484 $8.43 Million
Q3 2021 Nov 10, 2021	BUY	$23.84 - $32.03 $3.09 Million - $4.16 Million	129,758 Added 45.09%	417,510 $12.7 Million
Q2 2021 Aug 13, 2021	SELL	$29.06 - $38.83 $24,788 - $33,121	-853 Reduced 0.3%	287,752 $8.36 Million
Q1 2021 May 13, 2021	SELL	$39.04 - $64.6 $272,069 - $450,197	-6,969 Reduced 2.36%	288,605 $12.5 Million
Q4 2020 Feb 12, 2021	BUY	$42.46 - $56.58 $231,704 - $308,757	5,457 Added 1.88%	295,574 $13.7 Million
Q3 2020 Nov 12, 2020	SELL	$37.44 - $64.63 $266,872 - $460,682	-7,128 Reduced 2.4%	290,117 $12.6 Million
Q2 2020 Aug 11, 2020	BUY	$17.62 - $58.71 $402,458 - $1.34 Million	22,841 Added 8.32%	297,245 $15.8 Million
Q1 2020 May 14, 2020	BUY	$12.26 - $41.14 $3.36 Million - $11.3 Million	274,404 New	274,404 $6.13 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.